Takeda Pharmaceutical (TAK) Research & Development (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Research & Development of -$1.05 billion for the quarter ended Jun 30, 2026, compared with -$994.45 million a year earlier.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Takeda Pharmaceutical was -$4.53 billion; for the year ended Mar 31, 2026, it came in at -$4.49 billion.
- In prior years, Takeda Pharmaceutical's Research & Development was -$4.79 billion in the year ended Mar 31, 2025, -$5.06 billion in the year ended Mar 31, 2024, -$4.69 billion in the year ended Mar 31, 2023 and -$4.69 billion in the year ended Mar 31, 2022.
- Quarterly Research & Development has run from a low of -$1.42 billion in the quarter ended Mar 31, 2025 to a high of -$994.45 million in the quarter ended Jun 30, 2025 over five years.
- According to Business Quant data, Research & Development for the three prior quarters was -$1.25 billion (quarter ended Mar 31, 2026), -$1.14 billion (quarter ended Dec 31, 2025) and -$1.1 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.58 Bn | 537.11 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 507.51 Bn | 480.62 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 364.48 Bn | 318.85 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.05 Bn | 261.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.61 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.60 Bn | 191.00 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.42 Bn | 165.62 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.40 Bn | 117.05 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Takeda Pharmaceutical | 62.75 Bn | 39.12 Bn | 5.10 Bn | -1.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 Bn |
| Mar 31, 2026 | 7.37 Bn |
| Dec 31, 2025 | -1.14 Bn |
| Sep 30, 2025 | -1.10 Bn |
| Jun 30, 2025 | -994.45 Mn |
| Mar 31, 2025 | 8.16 Bn |
| Dec 31, 2024 | -1.12 Bn |
| Sep 30, 2024 | -1.18 Bn |
| Jun 30, 2024 | -1.08 Bn |
| Mar 31, 2024 | 8.53 Bn |
| Dec 31, 2023 | -1.27 Bn |
| Sep 30, 2023 | -1.27 Bn |
| Jun 30, 2023 | -1.19 Bn |
| Mar 31, 2023 | -1.23 Bn |
| Dec 31, 2022 | -1.24 Bn |
| Sep 30, 2022 | -1.12 Bn |
| Jun 30, 2022 | -1.11 Bn |
| Mar 31, 2022 | -1.24 Bn |
| Dec 31, 2021 | -1.13 Bn |
| Jun 30, 2021 | -1.12 Bn |
API Access
Takeda Pharmaceutical Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();